We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Bioventus
BVS
$1.19B
| $550K | ﹤0.01% |
105,680
+20,722
| +24% | +$101K |
|
|
AUGX
2252
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $547K | ﹤0.01% |
133,730
-122,227
| -48% | -$547K |
|
2253
EA Bridgeway Omni Small-Cap Value ETF
BSVO
$2.49B
| $547K | ﹤0.01% |
+25,700
| New | +$524K |
|
2254
Inogen
INGN
$164M
| $546K | ﹤0.01% |
67,694
-164,630
| -71% | -$1.17M |
|
|
NWLI
2255
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $546K | ﹤0.01% |
+1,110
| New | +$538K |
|
2256
Amkor Technology
AMKR
$13.7B
| $546K | ﹤0.01% |
16,934
-29,966
| -64% | -$950K |
|
2257
Great Southern Bancorp
GSBC
$878M
| $543K | ﹤0.01% |
9,902
+1,976
| +25% | +$105K |
|
2258
GCM Grosvenor
GCMG
$820M
| $537K | ﹤0.01% |
55,622
+19,601
| +54% | +$171K |
|
2259
Teradata
TDC
$2.55B
| $534K | ﹤0.01% |
13,799
-88,717
| -87% | -$3.74M |
|
|
SBR
2260
Sabine Royalty Trust
SBR
$1.05B
| $530K | ﹤0.01% |
8,337
-21,293
| -72% | -$1.33M |
|
|
PRSU
2261
Pursuit Attractions and Hospitality Inc
PRSU
$1.25B
| $530K | ﹤0.01% |
+13,412
| New | +$467K |
|
2262
Schrodinger
SDGR
$1.36B
| $529K | ﹤0.01% |
19,600
-2,000
| -9% | -$55.9K |
|
2263
Shift4
FOUR
$3.26B
| $529K | ﹤0.01% |
8,009
-38,554
| -83% | -$2.9M |
|
2264
GEN Restaurant Group
GENK
$10.5M
| $528K | ﹤0.01% |
45,241
-11,227
| -20% | -$92.7K |
|
2265
National Bank Holdings
NBHC
$1.9B
| $528K | ﹤0.01% |
+14,629
| New | +$508K |
|
|
DFSV
2266
Dimensional US Small Cap Value ETF
DFSV
$8.36B
| $527K | ﹤0.01% |
17,500
-48,200
| -73% | -$1.37M |
|
2267
Winmark
WINA
$1.32B
| $526K | ﹤0.01% |
1,453
-319
| -18% | -$117K |
|
2268
Alarm.com
ALRM
$2.85B
| $524K | ﹤0.01% |
7,232
-25,649
| -78% | -$1.74M |
|
2269
loanDepot
LDI
$516M
| $523K | ﹤0.01% |
202,027
+39,948
| +25% | +$107K |
|
2270
OSI Systems
OSIS
$3.89B
| $522K | ﹤0.01% |
+3,656
| New | +$480K |
|
2271
Napco Security Technologies
NSSC
$1.48B
| $522K | ﹤0.01% |
+13,000
| New | +$510K |
|
2272
SmartFinancial
SMBK
$888M
| $522K | ﹤0.01% |
24,774
-1,314
| -5% | -$29K |
|
|
COOP
2273
DELISTED
Mr. Cooper
COOP
| $522K | ﹤0.01% |
6,696
-50,491
| -88% | -$3.52M |
|
2274
Kyverna Therapeutics
KYTX
$484M
| $518K | ﹤0.01% |
+20,842
| New | +$582K |
|
|
SP
2275
DELISTED
SP Plus Corporation
SP
| $517K | ﹤0.01% |
9,909
-20,367
| -67% | -$1.05M |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.